News about Imperial technology development and commercial deals
Filter by theme
The UK Cystic Fibrosis Gene Therapy Consortium (GTC) is one of the partners in a licensing agreement with Boehringer Ingelheim. Read more
Imperial has licensed iNKT cell technology based on research by Prof. Tassos Karadimitris to SUDA Pharmaceuticals. Read more
Imperial will benefit from continued support for translational biomedical research under a unique technology transfer model. Read more
Sign up for updates
Sign up for monthly technology alerts via email, and find other ways to connect with us.